missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Pyrrolidines
  7. BMS-813160, MedChemExpress

BMS-813160, MedChemExpress

Product Code. p-200100890
Encompass_Preferred
Change view
Click to view available options
Quantity:
2 mg
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
2mg
50mg
5mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16434318 10 mg 10mg
16427037 5 mg 5mg
16420136 2 mg 2mg
16405236 100 mg 100mg
16400647 50 mg 50mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16434318 Supplier Medchem Express Supplier No. HY109593

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress BMS-813160 is the first dual CCR2/CCR5 antagonist, has the potential for cardiovascular treatment.

BMS-813160 is the first dual CCR2/CCR5 antagonist, has the potential for cardiovascular treatment.

Specifications

Chemical Name or Material BMS-813160
CAS 1286279-29-5
Color White
Purity Grade Notes Research
Molecular Formula C25H40N8O2
Quantity 10 mg
Solubility Information DMSO : 25 mg/mL (51.58 mM; Need ultrasonic and warming)
SMILES CC(N[C@H]1[C@@H](N2C([C@@H](NC3=NC=NC4=CC(C(C)(C)C)=NN43)CC2)=O)CC[C@@H](NC(C)(C)C)C1)=O
Molecular Weight (g/mol) 484.64
Formula Weight 484.64
Percent Purity 99.89%
Grade Research
Physical Form Solid
For Use With (Application) COVID-19-immunoregulation
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.